Literature DB >> 7909962

CD26 antigen and HIV fusion?

M Alizon, T Dragic.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7909962     DOI： 10.1126/science.7909962

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  6 in total

1.  Cell type-specific fusion cofactors determine human immunodeficiency virus type 1 tropism for T-cell lines versus primary macrophages.

Authors:  G Alkhatib; C C Broder; E A Berger
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

2.  A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains.

Authors:  J F Berson; D Long; B J Doranz; J Rucker; F R Jirik; R W Doms
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

3.  Proteinase-resistant factors in human erythrocyte membranes mediate CD4-dependent fusion with cells expressing human immunodeficiency virus type 1 envelope glycoproteins.

Authors:  T Dragic; L Picard; M Alizon
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

4.  Factors involved in entry of the human immunodeficiency virus type 1 into permissive cells: lack of evidence of a role for CD26.

Authors:  I Lazaro; D Naniche; N Signoret; A M Bernard; D Marguet; D Klatzmann; T Dragic; M Alizon; Q Sattentau
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

5.  Cellular CD44S as a determinant of human immunodeficiency virus type 1 infection and cellular tropism.

Authors:  C S Dukes; Y Yu; E D Rivadeneira; D L Sauls; H X Liao; B F Haynes; J B Weinberg
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

6.  Human immunodeficiency virus type 1 infection of SK-N-MC cells: domains of gp120 involved in entry into a CD4-negative, galactosyl ceramide/3' sulfo-galactosyl ceramide-positive cell line.

Authors:  J M Harouse; R G Collman; F González-Scarano
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.